These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 25743216)
41. Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies. Taha M; Ismail NH; Lalani S; Fatmi MQ; Atia-Tul-Wahab ; Siddiqui S; Khan KM; Imran S; Choudhary MI Eur J Med Chem; 2015 Mar; 92():387-400. PubMed ID: 25585009 [TBL] [Abstract][Full Text] [Related]
42. Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents. Sayahi MH; Zareei S; Halimi M; Alikhani M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Faramarzi MA; Rastegar H; Taslimi P; Ibrahim EH; Ghramh HA; Larijani B; Mahdavi M Sci Rep; 2024 Jul; 14(1):15791. PubMed ID: 38982268 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors. Han X; Zhong Y; Zhou G; Qi H; Li S; Ding Q; Liu Z; Song Y; Qiao X Bioorg Med Chem; 2017 Jun; 25(12):3116-3126. PubMed ID: 28462840 [TBL] [Abstract][Full Text] [Related]
44. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies. Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991 [TBL] [Abstract][Full Text] [Related]
45. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors. Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754 [TBL] [Abstract][Full Text] [Related]
46. 1,2,3-Triazole Tagged 3H-Pyrano[2,3-d]pyrimidine-6-carboxylate Derivatives: Synthesis, in Vitro Cytotoxicity, Molecular Docking and DNA Interaction Studies. Boda SK; Pishka V; Lakshmi PVA; Chinde S; Grover P Chem Biodivers; 2018 Jun; 15(6):e18000101. PubMed ID: 29660245 [TBL] [Abstract][Full Text] [Related]
48. Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study. Abuelizz HA; Anouar EH; Ahmad R; Azman NIIN; Marzouk M; Al-Salahi R PLoS One; 2019; 14(8):e0220379. PubMed ID: 31412050 [TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114 [TBL] [Abstract][Full Text] [Related]
50. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors. Xie Z; Wang G; Wang J; Chen M; Peng Y; Li L; Deng B; Chen S; Li W Molecules; 2017 Apr; 22(4):. PubMed ID: 28425975 [TBL] [Abstract][Full Text] [Related]
51. Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling. Rehman TU; Riaz S; Khan IU; Ashraf M; Bajda M; Gawalska A; Yar M Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29194730 [TBL] [Abstract][Full Text] [Related]
52. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors. Wang G; Wang J; He D; Li X; Li J; Peng Z Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456 [TBL] [Abstract][Full Text] [Related]
53. Synthesis, in vitro and computational studies of 1,4-disubstituted 1,2,3-triazoles as potential α-glucosidase inhibitors. Jabeen F; Shehzadi SA; Fatmi MQ; Shaheen S; Iqbal L; Afza N; Panda SS; Ansari FL Bioorg Med Chem Lett; 2016 Feb; 26(3):1029-1038. PubMed ID: 26725952 [TBL] [Abstract][Full Text] [Related]
54. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors. Kazmi M; Zaib S; Amjad ST; Khan I; Ibrar A; Saeed A; Iqbal J Bioorg Chem; 2017 Oct; 74():134-144. PubMed ID: 28780150 [TBL] [Abstract][Full Text] [Related]
55. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives. Wang G; Chen M; Qiu J; Xie Z; Cao A Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524 [TBL] [Abstract][Full Text] [Related]
56. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li J; Li X Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916 [TBL] [Abstract][Full Text] [Related]
57. Synthesis of novel flavone hydrazones: in-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies. Imran S; Taha M; Ismail NH; Kashif SM; Rahim F; Jamil W; Hariono M; Yusuf M; Wahab H Eur J Med Chem; 2015 Nov; 105():156-70. PubMed ID: 26491979 [TBL] [Abstract][Full Text] [Related]
58. Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies. Hameed S; Kanwal ; Seraj F; Rafique R; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Salar U; Taha M; Khan KM Eur J Med Chem; 2019 Dec; 183():111677. PubMed ID: 31514061 [TBL] [Abstract][Full Text] [Related]
59. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1. Bozorov K; Ma HR; Zhao JY; Zhao HQ; Chen H; Bobakulov K; Xin XL; Elmuradov B; Shakhidoyatov K; Aisa HA Eur J Med Chem; 2014 Sep; 84():739-45. PubMed ID: 25064350 [TBL] [Abstract][Full Text] [Related]
60. Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]